Protalix BioTherapeutics Inc (PLX)
1.335
+0.08
(+6.80%)
USD |
NYAM |
Nov 04, 13:10
Protalix BioTherapeutics Gross Profit Margin (Quarterly): 29.82% for June 30, 2024
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 29.82% |
| March 31, 2024 | 30.58% |
| December 31, 2023 | 15.54% |
| September 30, 2023 | 52.70% |
| June 30, 2023 | 82.47% |
| March 31, 2023 | 67.82% |
| December 31, 2022 | 72.18% |
| September 30, 2022 | 50.12% |
| June 30, 2022 | 53.31% |
| March 31, 2022 | 62.49% |
| December 31, 2021 | 63.18% |
| September 30, 2021 | 69.28% |
| June 30, 2021 | 26.36% |
| March 31, 2021 | 57.91% |
| December 31, 2020 | 85.88% |
| September 30, 2020 | 73.42% |
| June 30, 2020 | 83.34% |
| March 31, 2020 | 84.17% |
| December 31, 2019 | 83.39% |
| September 30, 2019 | 77.51% |
| June 30, 2019 | 77.99% |
| March 31, 2019 | 80.41% |
| December 31, 2018 | 78.00% |
| September 30, 2018 | 84.46% |
| June 30, 2018 | 54.88% |
| Date | Value |
|---|---|
| March 31, 2018 | 56.45% |
| December 31, 2017 | 63.90% |
| September 30, 2017 | 19.40% |
| June 30, 2017 | 13.13% |
| March 31, 2017 | 27.73% |
| December 31, 2016 | 6.20% |
| September 30, 2016 | 9.04% |
| June 30, 2016 | 5.31% |
| March 31, 2016 | 22.98% |
| December 31, 2015 | |
| September 30, 2015 | 83.31% |
| June 30, 2015 | 83.16% |
| March 31, 2015 | 83.33% |
| December 31, 2014 | 33.23% |
| September 30, 2014 | 51.50% |
| June 30, 2014 | 40.25% |
| March 31, 2014 | 44.83% |
| December 31, 2013 | 62.70% |
| September 30, 2013 | 52.75% |
| June 30, 2013 | 56.98% |
| March 31, 2013 | 75.53% |
| December 31, 2012 | -2.35K% |
| September 30, 2012 | 56.09% |
| June 30, 2012 | 87.02% |
| March 31, 2012 | 64.59% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
15.54%
Minimum
Dec 2023
85.88%
Maximum
Dec 2020
60.21%
Average
63.18%
Median
Dec 2021
Gross Profit Margin (Quarterly) Benchmarks
| Aethlon Medical Inc | -- |
| Predictive Oncology Inc | 45.12% |
| bluebird bio Inc | -79.78% |
| AIM ImmunoTech Inc | 84.00% |
| Armata Pharmaceuticals Inc | -- |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | -43.43% |
| Return on Assets | -16.63% |
| Return on Invested Capital | -27.15% |
| Profit Margin (Quarterly) | -16.35% |
| Operating Margin (Quarterly) | -18.01% |
| Return on Net Operating Assets | -38.91% |